Reprogramming immunosuppressive myeloid cells facilitates immunotherapy for colorectal cancer.
EMBO Mol Med. 2021 Jan 11;13(1):e12798. doi: 10.15252/emmm.202012798. Epub 2020 Dec 7.
EMBO Mol Med. 2021.
PMID: 33283987
Free PMC article.